GGrantIndex
← Leaderboards

Andrew Lewis Feldman

Mayo Clinic Rochester

$5,717,562
Attributed
$5,717,562
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3M · FY201322
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$11,861,403 · 4

By mechanism

P01$9,151,318 · 2
R01$1,639,727 · 1
P50$1,070,358 · 1

Top collaborators

Most similar at Mayo Clinic Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsLymphomaTumorDiagnosisBaseTranslational ResearchCellsTumor TissueResearch PersonnelClinicInnovationLeadBiometryGene ExpressionGeneticPathway InteractionsT-Cell LymphomaBioinformaticsProgramsPathologySamplingClassificationMolecular ProfilingHematology

Grant awards (17)

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$1,913,660
P01 · FY2022 · CA
Molecular Classification of Anaplastic Large Cell Lymphoma$604,916
P01 · FY2022 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,117,897
P01 · FY2021 · CA
Molecular Classification of Anaplastic Large Cell Lymphoma$594,813
P01 · FY2021 · CA · contact PI
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma$2,112,284
P01 · FY2020 · CA
Molecular Classification of Anaplastic Large Cell Lymphoma$594,811
P01 · FY2020 · CA · contact PI
Core B: Biospecimens$265,057
P50 · FY2020 · CA · contact PI
Molecular Classification of Anaplastic Large Cell Lymphoma$601,626
P01 · FY2019 · CA · contact PI
Core B: Biospecimens$261,505
P50 · FY2019 · CA · contact PI
Molecular Classification of Anaplastic Large Cell Lymphoma$611,311
P01 · FY2018 · CA · contact PI
Core B: Biospecimens$279,352
P50 · FY2018 · CA · contact PI
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas$329,925
R01 · FY2017 · CA · contact PI
Core B: Biospecimens$264,444
P50 · FY2017 · CA · contact PI
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas$329,925
R01 · FY2016 · CA · contact PI
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas$329,925
R01 · FY2015 · CA · contact PI
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas$320,027
R01 · FY2014 · CA · contact PI
Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas$329,925
R01 · FY2013 · CA · contact PI